{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:13:04Z","timestamp":1789708384776,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/s10156-012-0433-4","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T03:08:05Z","timestamp":1341284885000},"page":"883-890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Chronic hepatitis B in patients coinfected with human immunodeficiency virus in Japan: a retrospective multicenter analysis"],"prefix":"10.1016","volume":"18","author":[{"given":"Shintaro","family":"Yanagimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yotsuyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoji","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimi","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihisa","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junki","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Hige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Chayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-012-0433-4_bib0005","unstructured":"Ministry of Health, Labour and Welfare of Japan (ed). Annual Health, Labour and Welfare Report 2010\u20132011, Tokyo, Japan, 2011"},{"key":"10.1007\/s10156-012-0433-4_bib0010","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study","volume":"166","author":"Weber","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1007\/s10156-012-0433-4_bib0015","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1086\/381444","article-title":"Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors","volume":"38","author":"Sulkowski","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-012-0433-4_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/QCO.0b013e32834ef599","article-title":"From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management","volume":"25","author":"Lemoine","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1007\/s10156-012-0433-4_bib0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1468-1293.2008.00662.x","article-title":"Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort","volume":"10","author":"Chaudhry","year":"2009","journal-title":"HIV Med"},{"key":"10.1007\/s10156-012-0433-4_bib0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000324525","article-title":"Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale","volume":"54","author":"Tanaka","year":"2011","journal-title":"Intervirology"},{"key":"10.1007\/s10156-012-0433-4_bib0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1872-034X.2007.00263.x","article-title":"Prevalence of hepatitis B virus infection in Japanese patients with HIV","volume":"38","author":"Koike","year":"2008","journal-title":"Hepatol Res"},{"key":"10.1007\/s10156-012-0433-4_bib0040","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2893.2009.01249.x","article-title":"Prevalence of chronic hepatitis B virus infection among patients in the HIV Outpatient Study, 1996\u20132007","volume":"17","author":"Spradling","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1007\/s10156-012-0433-4_bib0045","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.jhep.2005.11.004","article-title":"Epidemiology of viral hepatitis and HIV co-infection","volume":"44","author":"Alter","year":"2006","journal-title":"J Hepatol"},{"key":"10.1007\/s10156-012-0433-4_bib0050","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/hep.21722","article-title":"HIV and liver disease forum: conference proceedings","volume":"45","author":"Sherman","year":"2007","journal-title":"Hepatology"},{"issue":"suppl 3","key":"10.1007\/s10156-012-0433-4_bib0055","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/01.aids.0000192069.95819.aa","article-title":"Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention","volume":"19","author":"Weinbaum","year":"2005","journal-title":"AIDS"},{"key":"10.1007\/s10156-012-0433-4_bib0060","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jhep.2005.01.022","article-title":"Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol","volume":"42","author":"Salmon-Ceron","year":"2005","journal-title":"J Hepatol"},{"key":"10.1007\/s10156-012-0433-4_bib0065","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","article-title":"HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)","volume":"360","author":"Thio","year":"2002","journal-title":"Lancet"},{"key":"10.1007\/s10156-012-0433-4_bib0070","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1517\/14656566.2010.500615","article-title":"Management of HIV and hepatitis virus coinfection","volume":"11","author":"Mendes-Correa","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1007\/s10156-012-0433-4_bib0075","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/514750","article-title":"Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine","volume":"28","author":"Bessesen","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-012-0433-4_bib0080","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1007\/s10156-012-0433-4_bib0085","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2893.2006.00797.x","article-title":"Treatment of hepatitis B with lamivudine and tenofovir in HIV\/HBV-coinfected patients: factors associated with response","volume":"14","author":"Jain","year":"2007","journal-title":"J Viral Hepat"},{"key":"10.1007\/s10156-012-0433-4_bib0090","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/aid.2006.0172","article-title":"Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B","volume":"23","author":"Quarleri","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1007\/s10156-012-0433-4_bib0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.283.1.74","article-title":"Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection","volume":"283","author":"Sulkowski","year":"2000","journal-title":"JAMA"},{"key":"10.1007\/s10156-012-0433-4_bib0100","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1097\/00002030-200012220-00011","article-title":"Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection","volume":"14","author":"den Brinker","year":"2000","journal-title":"AIDS"},{"key":"10.1007\/s10156-012-0433-4_bib0105","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/jama.1990.03440090052025","article-title":"The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies","volume":"263","author":"Alter","year":"1990","journal-title":"JAMA"},{"key":"10.1007\/s10156-012-0433-4_bib0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0166-0934(99)00039-7","article-title":"Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product","volume":"80","author":"Usuda","year":"1999","journal-title":"J Virol Methods"},{"key":"10.1007\/s10156-012-0433-4_bib0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0166-0934(00)00153-1","article-title":"Differentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product","volume":"87","author":"Usuda","year":"2000","journal-title":"J Virol Methods"},{"key":"10.1007\/s10156-012-0433-4_bib0120","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/QAD.0b013e328344fe96","article-title":"New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B","volume":"25","author":"Soriano","year":"2011","journal-title":"AIDS"},{"key":"10.1007\/s10156-012-0433-4_bib0125","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000074988","article-title":"Classifying hepatitis B virus genotypes","volume":"46","author":"Miyakawa","year":"2003","journal-title":"Intervirology"},{"key":"10.1007\/s10156-012-0433-4_bib0130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jmv.20319","article-title":"Characterization of seven genotypes (A to E, G and H) of hepatitis B virus recovered from Japanese patients infected with human immunodeficiency virus type 1","volume":"76","author":"Shibayama","year":"2005","journal-title":"J Med Virol"},{"key":"10.1007\/s10156-012-0433-4_bib0135","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/jhep.2001.27221","article-title":"Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan","volume":"34","author":"Orito","year":"2001","journal-title":"Hepatology"},{"key":"10.1007\/s10156-012-0433-4_bib0140","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/JCM.02081-08","article-title":"Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A","volume":"47","author":"Matsuura","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1007\/s10156-012-0433-4_bib0145","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/jmv.1069","article-title":"Predominance of genotype A HBV in an HBV-HIV-1 dually positive population compared with an HIV-1-negative counterpart in Japan","volume":"64","author":"Koibuchi","year":"2001","journal-title":"J Med Virol"},{"key":"10.1007\/s10156-012-0433-4_bib0150","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/QAD.0b013e328345ef5e","article-title":"Managing hepatitis B\/HIV co-infected: adding entecavir to truvada (tenofovir disoproxil\/emtricitabine) experienced patients","volume":"25","author":"Ratcliffe","year":"2011","journal-title":"AIDS"},{"key":"10.1007\/s10156-012-0433-4_bib0155","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1478-3231.2011.02676.x","article-title":"Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis","volume":"32","author":"Hyun","year":"2012","journal-title":"Liver Int"},{"key":"10.1007\/s10156-012-0433-4_bib0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/gast.2003.50013","article-title":"Histological outcome during long-term lamivudine therapy","volume":"124","author":"Dienstag","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1007\/s10156-012-0433-4_bib0165","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000071457","article-title":"Histological improvements after a three-year lamivudine therapy in patients with chronic hepatitis B in whom YMDD mutants did not or did develop","volume":"46","author":"Suzuki","year":"2003","journal-title":"Intervirology"},{"key":"10.1007\/s10156-012-0433-4_bib0170","first-page":"1159","article-title":"Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinoma","volume":"13","author":"Hiraoka","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1007\/s10156-012-0433-4_bib0175","doi-asserted-by":"crossref","first-page":"12671","DOI":"10.1073\/pnas.231140698","article-title":"Mechanism of indinavir-induced hyperbilirubinemia","volume":"98","author":"Zucker","year":"2001","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X12702155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X12702155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10156-012-0433-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:48:09Z","timestamp":1761158889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X12702155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"alternative-id":["S1341321X12702155"],"URL":"https:\/\/doi.org\/10.1007\/s10156-012-0433-4","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic hepatitis B in patients coinfected with human immunodeficiency virus in Japan: a retrospective multicenter analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-012-0433-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}